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 Introductions: De Quervain tenosynovitis is a common cause of 
functional impairment. Steroid injection has good result but significant 
numbers of cases develop resistance requiring surgical decompression. 
This study assesses the outcome of surgery. 
 
Methods: Symptomatic de Quervaint tenosynovitis cases resistant to 
conservative treatment that underwent surgical decompression and 
postoperative thumb immobilization using thumb spica splint cast during 
four and half years were analyzed. They were followed for at least three 
months for clinical and functional outcome. Patient demography, visual 
analogue score (VAS) and complications were analyzed descriptively. 
 
Results: There were 34 cases of de Quervaint tenosynovitis, mean age 
42±16 years, and female 88.2%. Treatment was successful in all cases. 
The mean VAS score reduced to 0.5 from 6.82, p-value <0.01. 
Complication occurred in one case. 
 
Conclusions: Surgical decompression of de Quervain tenosynovitis was 
safe and effective in cases resistant to conservative treatment. 
 
Keywords: corticosteroid injection CSI, resistant de Quervain 
tenosynovitis, surgical decompression, thumb spica splint cast 
ISSN: 2091-2749 (Print) 
          2091-2757 (Online) 
 
 





Dr. Nabees Man Singh Pradhan 




Dr. Sumana Bajracharya 














BB KC: Surgery for De Quervain's tenosynovitis 





De Quervain's tenosynovitis was first 
recognized in 1895 by Fritz De Quervain as a 
stenosing tenosynovitis of the abductor pollicis 
longus (APL) and the extensor pollicis brevis 
(EPB).1,2 The repeated activity of the wrist with 
abducted and extended thumb is the cause for 
the development of the lesion.3 Prevalence of 
this condition is found in 1.2% of general 
population, with age more than 40 years, 
female and black race being the risk factors.4,5 
 
The conservative nonsurgical treatment, 
include rest, massage, diathermy, casting, oral 
analgesics, and local steroid injection.2,6,7 
Intralesional corticosteroid injection (CSI) is an 
effective form of treatment commonly 
practiced nowadays.  
 
Surgical intervention is definitive therapy for 
De Quervain’s tenosynovitis if all other 
treatment methods fail and is more likely to be 
satisfactory for patients with a long duration of 
symptoms.8,9 This is associated with variable 
outcome and wide intraoperative variation in 
anatomical structure. 
 
In this review, we aim to assess the outcome 
of decompression surgery in patients’ resistant 






Patients with de Quervain’s tenosynovitis 
presenting over a period of five and half years 
(June 2013 to February 2017) who underwent 
surgical release in Kaski Model Hospital, 
Pokhara, Nepal, were evaluated 
retrospectively. Patients between the age of 
20 to 80 years with duration of symptoms for 
more than three months who were resistant to 
other forms of treatment and visual analogue 
scale (VAS) score for pain more than five at the 
time of presentation were included in the 
study.  
 
The patients with chronic disease and co-
morbidities like diabetes and arthritis of the 
joints of hands, and previous history of surgical 
procedure for same condition or same site 
were excluded.  
 
After taking written consent from the patients, 
surgery was done under local anesthesia. 
Transverse incision was given at the level of 
maximum tenderness (1.5 cm proximal to the 
tip of radial styloid process in most of the 
cases) and the compartment reached through 
blunt dissection protecting superficial sensory 
branch of radial nerve. Decompression was 
done by incising the extensor retinaculum of 
first dorsal compartment of wrist along the line 
of APL and EPB tendon leaving the volar flap 
intact. Both the tendons were identified and 
complete decompression confirmed using 
atraumatic passive tendon movement. 
Postoperatively after closing the skin, thumb 
was immobilized using thumb spica splint and 
suture was taken out on 14th postoperative 
day. The patient was asked to continue the 
normal activity as tolerated; and followed at 
two, six and 12 weeks for movement and VAS 
score. 
 
Treatment was considered successful if patient 
had no pain or tenderness with negative 
Finkelstein test. 
 
Statistical analysis was done using the SPSS 
version 21.0.  The p-value less than 0.05 was 






Thirty-four patients underwent decompression 
surgery. The average age was 42±16 years, 12 
(35.3%) in 20 to 30 years age group (Figure 1). 
Female were 30 (88.2%), (Table 1). Left hand 
was involved in 20 (58.8%) and mean duration 
of symptoms was 152±56 days. Treatment was 
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Figure 1. Age distribution of patients of resistant de Quervain tenosynovitis 
 
 
Table 1. Sex distribution of de Quervain tenosynovitis in different studies 
 
 
Study Characteristics Women’s Wrist Men’s Wrist 
Weiss et al.13 1994 80 13 
Harvey et al.14 1990 70 12 
Anderson et al.15 1991 50 5 
Witt et al.16 1991 64 19 
McKenzie.17 1972 25 5 
Zingas et al.18 1998 12 7 
Christie.19 1955 16 4 
Mardani-Kivi et al.20 2014 47 12 
Our Study 30 4 
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The mean VAS score before surgery was 
6.82±0.17, and after surgery 0.5±0.14 at six 
weeks (p =<0.01) and 0.12±0.07 at 12 weeks (p 
=<0.01). 
 
Anatomical variation was found in 20 cases, 16 
(47%) had septation of first compartment and 
4 (11.8%) had multiple APL slips. 
 
One (2.9%) patient developed paresthesia 
along the distribution of radial sensory branch. 





In our study female were 30 (88.2%) 
significantly higher than male. Similar findings 
is reported in others series, (Table 1). More 
cases in women could reflect both biological 
predispositions (hormonal effect) and 
overexposure to biomechanical repetitive 
work-related constraints (gender effect). 
 
At the early years of 20th century, surgical 
release of first dorsal compartment were 
mostly used.10,11 Surgery is reserved for those 
with intense chronic pain unresponsive to 
conservative treatment.12 
 
Mean age group in our study was 42±16 years. 
Age greater than 40 has been reported as a 
risk factor.5 Mean duration of symptom in our 
study was 152±56 days. The longer duration 
before presentation could be due to the 
inclusion criteria of resistant cases only and 
lack of availability of health facilities.  
 
Our study shows more involvement of left 
wrist, 20 (58.8%), in contrast to other 
studies.20,12 One possibility could be our 
patients were more left handed.  
 
In the final follow-up visit, the treatment was 
successful in all patients (100%). The study by 
Lamichhane N. et al., unpublished research 
thesis, Maharajgunj Medical Campus, Institute 
of Medicine, Tribhuvan University, Kathmandu, 
Nepal, reported a success rate of 89.7% (35 
out of 39 patients) in patient who received CSI 
plus thumb spica cast (TSC) compared to 50% 
(18 out of 36 patients) in case of patients who 
received CSI. Our result was similar to the most 
of the study done with surgical 
decompression.9,21 Reduction in VAS score was 
significantly better than other techniques of 
treatment like SCI or SCI with TSC application.20 
 
We found septation in 47% and multiple APL 
slips in 11.8% of our 34 cases. In contrast, the 
cadaveric study reports anatomical variation of 
multiple septation of APL in 57.6% and 
septation of first dorsal compartment in 47% in 
66 cases.22 This indicates that the failure of 
treatment with corticosteroid injection may 
contribute to this anatomical variation and 
ultrasound guided injection may result in less 
number of resistant cases. 
 
We had 2.9% (1 out of 34 cases) complications 
of temporary neuropraxia. Complications like 
fat necrosis, subcutaneous atrophy, and skin 
depigmentation has been reported in 5-10% of 
CSI and 9% recurrence of de Quervain’s 
tenosynovitis, radial sensory nerve injury, and 
severe scar tenderness after surgery.8 Like in 
our cases, transverse incision in surgical 
decompression is associated with lower 
complications rate. 
 
Some of the limitation of our study could be 
absence of a control group. Bigger sample size 
through multi-center enrolment and longer 
follow up could provide better insight in long 





Surgical release of de Quervain’s tenosynovitis 
in resistant cases was safe and effective in all 
34 cases at 12 weeks follow up. We had one 
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